Use Versus Non-use of Bladder Catheterization in Elective Cesarean Delivery
Launched by UNIVERSITY OF CALGARY · Feb 2, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether using a bladder catheter during elective cesarean sections (C-sections) can improve patient outcomes. The researchers want to find out if routine catheterization affects how long women stay in the hospital, how quickly they can get up and move around after surgery, and if it helps prevent issues like urinary retention (difficulty urinating) or urinary tract infections. They are also interested in whether using a catheter can help avoid bladder injuries and improve overall patient satisfaction with their care.
To participate in this trial, women aged 18 and older who are having a planned C-section with a single baby are eligible. However, those with certain complications related to the placenta, such as placenta previa, cannot take part. If you join the study, you will be randomly assigned to either receive a bladder catheter during your surgery or not. This means you may or may not have the catheter placed, but the goal is to see which approach helps patients recover better after their C-section. The trial is currently actively recruiting participants, and your involvement could contribute to important findings that enhance care for future mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion criteria:
- • - women who are 18 years of age or older with a singleton pregnancy presenting for an elective primary or repeat CS.
- Exclusion criteria:
- • - diagnosis of abnormal placentation including placenta previa, vasa previa, or suspected invasive disease
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Stephen L. Wood, MD, MSc
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported